COMPANY PROFILE / #1283
Expedition Medicines
Cambridge, MAVenture Capital-Backed
OVERVIEW
Developer of a drug discovery platform designed to generate small molecule drugs for previously inaccessible disease targets. The company's platform features continuous chemoproteomics data generation, quantum chemistry-powered artificial intelligence for mapping covalent bond formation at atomic precision, and generative molecular design, enabling pharmaceutical researchers to access undruggable protein surfaces and advance therapies across oncology, immunology, and other diseases.
已融资50.00
最新估值170.00
员工数36
成立年份2022
公司概况
- Companies
- Expedition Medicines
- Description
- Developer of a drug discovery platform designed to generate small molecule drugs for previously inaccessible disease targets. The company's platform features continuous chemoproteomics data generation, quantum chemistry-powered artificial intelligence for mapping covalent bond formation at atomic precision, and generative molecular design, enabling pharmaceutical researchers to access undruggable protein surfaces and advance therapies across oncology, immunology, and other diseases.
- Website
- www.expeditionmedicines.com
- HQ Location
- Cambridge, MA
- Year Founded
- 2022
- Keywords
- chemoproteomics technology, covalent drugs, drug discovery ai, immunology drug, oncology drug discovery, quantum chemistry, undruggable targets
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 50.00
- First Financing Date
- —
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 22-Oct-2025
- Last Financing Deal Type
- Early Stage VC
- Last Financing Size
- 50.00
- Last Financing Valuation
- 170.00
- Last Financing Status
- Completed
- Last Known Valuation
- 170.00
- Last Known Valuation Date
- 22-Oct-2025
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- 285.09
- Valuation Estimate Growth Rate
- 67.70%
- Active Investors
- Altitude Life Science Ventures, Flagship Pioneering
- # Active Investors
- 2
- Acquirers
- —
团队与联系人
- Employees
- 36
- Employee Growth %
- —
- Employee History
- 2025: 36
- Primary Contact
- Molly Gibson
- Primary Contact Title
- Co-Founder and Chief Executive Officer
- Primary Contact Email
- mgibson@flagshippioneering.com
- Primary Contact Phone
- +1 (617) 868-1888
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 1.35x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 61
- Majestic Referring Domains
- 35
- SimilarWeb Unique Visitors
- 159
- SimilarWeb Unique Visitors Change
- -4
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- —
- Success Probability Over Time – 3 Year
- —
- Success Probability Over Time – 5 Year
- —
记录来源：public.companies · 原始序号 #1283 · 所有字段均按数据库原值展示。